Clinical Trial Update: Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting safety and efficacy results for the true human antibody 514G3 in adults with Staphylococcus aureus bacteremia (Phase 1/Phase 2; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia

Drugs mentioned

• 514G3 (human monoclonal antibody 514G3)

Snippet

Sponsor: XBiotech, Inc. | Conditions: Staphylococcus Aureus Bacteremia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-21